Statin therapy and lipoprotein(a) levels: a systematic review and meta-analysis.

Lotte M de BoerAnna O J OorthuysAlbert WiegmanMiranda W Langendam Jeffrey Kroon Rene SpijkerAeilko H ZwindermanBarbara A Hutten

Published in: European journal of preventive cardiology (2021)

Statin therapy does not lead to clinically important differences in Lp(a) compared to placebo in patients at risk for CVD. Our findings suggest that in these patients, statin therapy will not change Lp(a)-associated CVD risk.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
cardiovascular disease
coronary artery disease
prognostic factors
type diabetes
randomized controlled trial
clinical trial
patient reported outcomes
low density lipoprotein